Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sun Pharmaceutical Industries Limited
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or nonpregnant female aged 18 years or older with chronic open angle glaucoma or ocular hypertension in both eyes.
Provide signed and dated informed consent in accordance with good clinical practice and local legislation prior to any study procedure.
Be able and willing to follow study instructions and complete all required visits.
Subject requires treatment of both eyes and is able to discontinue use of all ocular hypotensive medication(s) or switch ocular hypotensive medications and undergo appropriate washout period.
You may not be if
Subjects with angle closure glaucoma
Females who are pregnant, breast feeding, or planning a pregnancy.
Females of childbearing potential who do not agree to utilize an adequate form of contraception.
Current, or past history of, severe hepatic or renal impairment
Current, or history within 2 months prior to baseline of, significant ocular disease
Functionally significant visual field loss
Contraindication to brinzolamide or sulfonamide therapy or known hypersensitivity to any component of brinzolamide or sulfonamide therapy
Subjects currently in another clinical trial
Clareo Health | A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
